Evidence map›Paper›PMID 40687500›Full record

ArticleACS applied polymer materials2025

Poly (hydroxyethyl methacrylate) Saliva-Gel: A Polymer-Based Solution for Xerostomia Treatment.

Suman Debnath, Cristina Paz, Dimitri Scofield, Nicole Rogus-Pulia, Randall J Kimple, Georgia A Malandraki, Bryan W Boudouris

Abstract read
In one paragraph

Article in ACS applied polymer materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Suman DebnathCharles D. Davidson School of Chemical Engineering, Purdue University, West Lafayette, IN 47907 USA.
Cristina PazDepartment of Human Oncology, University of Wisconsin School of Medicine and Public Health, University of Wisconsin, Madison, WI 53706 USA.
Dimitri ScofieldDepartment of Human Oncology, University of Wisconsin School of Medicine and Public Health, University of Wisconsin, Madison, WI 53706 USA.
Nicole Rogus-PuliaDivision of Geriatrics and Gerontology, Department of Medicine, School of Medicine and Public Health, University of Wisconsin, Madison, WI 53706 USA.
Randall J KimpleDepartment of Human Oncology, University of Wisconsin School of Medicine and Public Health, University of Wisconsin, Madison, WI 53706 USA.
Georgia A MalandrakiSpeech, Language and Hearing Sciences, Purdue University, West Lafayette, IN 47907 USA.
Bryan W BoudourisCharles D. Davidson School of Chemical Engineering, Purdue University, West Lafayette, IN 47907 USA.

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Justine Yang Bruce · 1985 to 2026
$142.6M
Intra-salivary gland autotransplantation of marrow mesenchymal stromal cells for treatment of radiation induced xerostomiaUH3DE030431 · NIDCR · UNIVERSITY OF WISCONSIN-MADISON · PI Jacques Galipeau, Randall J. Kimple · 2023 to 2026
$2.0M
Impact of Novel Rehabilitative Approaches FOR Dysphagia in Patients with Alzheimer's Disease and Related DementiasK76AG068590 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI ROGUS-PULIA, NICOLE M · 2020 to 2023
$1.3M
Intra-salivary gland autotransplantation of marrow mesenchymal stromal cells for treatment of radiation induced xerostomiaUG3DE030431 · NIDCR · UNIVERSITY OF WISCONSIN-MADISON · PI KIMPLE, RANDALL J. · 2021 to 2021
$312k
Mesenchymal stromal cells for treatment of radiation-induced xerostomiaF31DE031180 · NIDCR · UNIVERSITY OF WISCONSIN-MADISON · PI PAZ, CRISTINA · 2022 to 2024
$112k
NCI NIH HHS P30 CA014520NIA NIH HHS K76 AG068590NIDCR NIH HHS F31 DE031180NIDCR NIH HHS UG3 DE030431NIDCR NIH HHS UH3 DE030431
6 · The paper itself

Abstract

Dry mouth (xerostomia) often leads to difficulties in swallowing, speaking, and maintaining good oral hygiene. Present therapeutic interventions for xerostomia yield temporary symptom alleviation or are invasive. In this study, we employ the biocompatible polymer, poly(hydroxyethyl methacrylate) (PHEMA), to create a PHEMA-based saliva-gel to regulate the release of artificial saliva and emulate the properties of natural salivary secretion as a non-invasive dry mouth treatment mechanism. The saliva-gel exhibited a swelling capacity of approximately 400% of its original volume within 6 h. The high swelling capacity of the saliva-gel allows it to absorb and retain a significant amount of saliva, effectively increasing the amount of oral saliva and potentially providing sustained relief from dryness. The optimized saliva-gel exhibited a release rate of nearly all its stored artificial saliva within 4 h at body temperature and exhibited a 97% efficiency in its release properties, which remained consistent through five continuous cycles. It also demonstrated reusable absorbance properties for these five cycles. The release rate of the saliva-gel, aligns with the goal of providing timely relief for dry mouth symptoms. These findings collectively suggest that the study successfully demonstrates the potential of these materials for the treatment of xerostomia.

Indexed as

Bioinspired saliva-gelOral care materialsPHEMA-based saliva-gelSaliva release dynamicsXerostomia

Identifiers

PMID40687500
PMCPMC12270425

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.